Universal Pharmaceuticals Private Limited, a active private limited company, was established on 27 July 1990 in Chennai, Tamil Nadu, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231TN1990PTC019449. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹0.51 M.
Formerly known as Universal Pharmaceuticals Ltd.. It upholds a compliant status. Employing 50 professional, Its leadership includes Shew Ratan Marda (Director), Kalimuthu Babu (Additional Director). Past directors included Parambath Sreenivasan Padmanabhan Nair, Sivakumar Swaminathan. It holds ₹9.80 Cr open charges and ₹4.08 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at No1,Grihalakshmi Shopping Complex Vaidyanathan Street,Tondiarpet,, Chennai, Tamil Nadu, 600081.
U24231TN1990PTC019449
019449
27 July 1990
₹1.00 Cr
₹0.51 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Universal Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shew Ratan Marda | Director | 10 Aug 2006 | Current |
| Kalimuthu Babu | Additional Director | 02 Nov 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 25 Apr 2022 | Past |
| Pramod Abcsdd | Director | 23 Nov 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Universal Pharmaceuticals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 5.68% increase. The company also saw a substantial improvement in profitability, with a 89.81% increase in profit. The company's net worth observed a substantial decline by a decrease of 112.59%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Universal Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹98,034,000.00
₹40,760,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Dec 2017 | Canara Bank | ₹0.55 M | Open |
| 21 Sep 2006 | Canara Bank | ₹4.29 Cr | Open |
| 14 Aug 2004 | Indian Bank | ₹2.73 Cr | Open |
| 14 Aug 2004 | Indian Bank | ₹2.73 Cr | Open |
| 02 Jun 2005 | Icici Bank Limted | ₹2.04 Cr | Satisfied |
Explore comprehensive loan charge details -
Universal Pharmaceuticals has a workforce of 50 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Universal Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Universal Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Universal Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Universal Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was documented.
Progress on Kalimuthu Babu was appointed as a Additional Director was appointed as a Additional Director on 02 Nov 2023 & has been associated with this company since 2 years 28 days . was documented.
Progress on A charge with Canara Bank of Rs. 4.29 Cr registered on 21 Sep 2006 with Charge ID 10022867 was modified on 15 Jun 2020. was documented.
Progress on A charge with Canara Bank amounted to Rs. 0.06 Cr with Charge ID 100193669 was registered on 30 Dec 2017. was documented.
The activity A charge registered on 02 Jun 2005 via Charge ID 80059336 with Icici Bank Limted was fully satisfied on 11 Jun 2010. was completed.
The CIN of Universal Pharmaceuticals Private Limited is U24231TN1990PTC019449.
Universal Pharmaceuticals Private Limited is headquartered at No1,Grihalakshmi Shopping Complex Vaidyanathan Street,Tondiarpet,, Chennai, Tamil Nadu, 600081.
Universal Pharmaceuticals Private Limited was incorporated on 27 July 1990.
The current directors of Universal Pharmaceuticals Private Limited are
The primary industry of Universal Pharmaceuticals Private Limited is Manufacturing.
Universal Pharmaceuticals Private Limited is unlisted.
The authorized capital of Universal Pharmaceuticals Private Limited is ₹1.00 Cr, and the paid-up capital is ₹0.51 M.
The compliance status of Universal Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX